ERBB2 and small cell lung carcinoma: A recent study with HER2-positive small-cell lung cancer cells demonstrated that the cell surface-binding of trastuzumab diminished with time during incubation at 37°C and was internalized, while most trastuzumab did not internalize and remained on the cell surface when incubated at 4°C without warming to 37°C [26].